IMH to Provide Public Registration for “Sinopharm” by Next Week
IMH will provide Sinopharm Covid-19 vaccine later this month. The registration process will begin next week.
Mr. Sittiwat Kamkatwong, Chief Executive Officer of Intermedical Care and Lab Hospital Public Company Limited (IMH), stated that the company has been selected by Chulabhorn Royal Academy to be a Covid-19 vaccination center for the Sinopharm Covid-19 vaccine.
The vaccine will be available for the general public to register for the jab by next week, and the vaccination will start by the end of the month.